Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2023) Vol. 11, Iss. 11, pp. 1634-1634
Open Access | Times Cited: 13

Showing 13 citing articles:

Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults
Jorge Quarleri, M. Victoria Delpino, Verónica Galván
GeroScience (2024) Vol. 46, Iss. 3, pp. 2879-2883
Open Access | Times Cited: 18
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 10
Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera
Najat Bdeir, Tatjana Lüddecke, Henrike Maaß, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Reverse mutational scanning of spike BA.2.86 identifies the epitopes contributing to immune escape from polyclonal sera
Najat Bdeir, Tatjana Lüddecke, Henrike Maaß, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
The impact of Omicron on the COVID-19 vaccines: A review
Pragya D. Yadav, Deepak Y. Patil, Rima R. Sahay, et al.
Vacunas (2024) Vol. 25, Iss. 2, pp. 274-284
Closed Access | Times Cited: 3
Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain
Víctor López de Rioja, Luca Basile, Aida Perramon, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 466-466
Open Access | Times Cited: 3
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2024) Vol. 12, Iss. 8, pp. 887-887
Open Access | Times Cited: 3
Sublines of Omicron Genovariant of SARS-CoV-2 Virus as Potential Dominant Agents of New Rises of COVID-19 Morbidity in Russia
Т. Е. Сизикова, N. V. Karulina, A. A. Petrov, et al.
Journal of NBC Protection Corps (2024) Vol. 7, Iss. 4, pp. 338-349
Open Access
Genomic surveillance and sequencing of SARS-CoV-2 in Malaysia
Norazimah Tajudin, Seok Mui Wang, Darshan Chandra Kumar, et al.
Asia-Pacific Journal of Molecular Biology and Biotechnology (2024), pp. 71-83
Open Access
The impact of Omicron on the COVID-19 vaccines: A review
Pragya D. Yadav, Deepak Y. Patil, Rima R. Sahay, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 2, pp. 274-284
Closed Access
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study
Ivan Gentile, Giulio Viceconte, F. M. Cuccurullo, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access
Urgent need to address neglect of SARS Co-V2 omicron BA.2.86 (Pirola) and Arcturus (XBB.1.16) variants in Southeast Asia
Hinpetch Daungsupawong, Viroj Wiwanitkit
Santosh University Journal of Health Sciences (2024) Vol. 10, Iss. 2, pp. 347-348
Closed Access
The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins
Arjan Bains, Kathryn Fischer, Wenyan Guan, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2452-2452
Open Access
Page 1

Scroll to top